Your session is about to expire
← Back to Search
Radiation
LITT + Radiation for Brain Tumor (GCCC 19140 Trial)
N/A
Recruiting
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 22 years old
Patient must have received prior radiation therapy for initial treatment of glioma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
GCCC 19140 Trial Summary
This trial is testing a new way to treat patients with brain tumors that have come back. The treatment involves using a laser to heat up and destroy the tumor, and then using radiation to kill any remaining cancer cells.
Who is the study for?
This trial is for adults over 22 with recurrent WHO Grade II-IV gliomas, who've had prior radiation therapy. They must have a tumor ≤ 6 cm, not undergone re-irradiation, and be in good enough health to undergo surgery. Women of childbearing age need a negative pregnancy test and all participants must agree to use contraception.Check my eligibility
What is being tested?
The study tests using Laser Interstitial Thermal Therapy (LITT) followed by Hypo-fractionated Radiation Therapy on patients with recurring brain tumors called gliomas. It aims to see how effective this combination is for treatment after initial therapies have failed.See study design
What are the potential side effects?
Potential side effects may include typical risks associated with surgical procedures like LITT and radiation therapy such as infection, bleeding, neurological damage or deficits, fatigue from radiation, skin irritation at the treatment site, and other organ-specific reactions.
GCCC 19140 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 22 years old or older.
Select...
I have had radiation therapy for my brain tumor before.
Select...
I can care for myself but may need occasional help.
Select...
My brain tumor has come back or gotten worse after treatment.
Select...
It has been at least 8 weeks since my last radiation treatment.
GCCC 19140 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse Events
Secondary outcome measures
1-year overall survival
Median overall survival
Median progression-free survival
+3 moreGCCC 19140 Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental: LITT with Hypofractionated radiation therapyExperimental Treatment2 Interventions
Laser interstitial thermal therapy (LITT) followed by hypo-fractionated radiation therapy, 35Gy/10 fractions.
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,624 Total Patients Enrolled
3 Trials studying Glioblastoma
63 Patients Enrolled for Glioblastoma
Keep Punching FoundationUNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
1 Trials studying Glioblastoma
32 Patients Enrolled for Glioblastoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer has spread to the lower part of my brain or its lining.My brain MRI shows a tumor 6 cm or smaller.I am 22 years old or older.You cannot have a MRI scan.I have had radiation therapy for my brain tumor before.I have had cancer come back but haven't had repeat radiation therapy.I am a woman who can have children and I have a negative pregnancy test from the last 28 days.I will only get more radiation if tests after my laser therapy show cancer has returned.I cannot undergo surgery for a stereotactic biopsy or laser ablation.I have heart problems that affect my daily activities.I can care for myself but may need occasional help.My brain tumor has come back or gotten worse after treatment.It has been at least 8 weeks since my last radiation treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental: LITT with Hypofractionated radiation therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current participant count for this investigation?
"Affirmative, the information present on clinicaltrials.gov reveals that this medical experiment is actively searching for subjects. It was initially posted online on August 1st 2020 and updated lastly on October 10th 2022. 32 individuals are necessary from 4 different research sites."
Answered by AI
To what extent is this trial being conducted in hospitals across the country?
"This trial is currently being conducted at 4 separate facilities located in Bel Air, Glen Burnie, Columbia and a few other locations. To reduce commute times for participants, it may be best to select the clinic that is geographically closest."
Answered by AI
Are participants still being recruited for this trial?
"Affirmative, the information hosted on clinicaltrials.gov indicate that this medical experiment is actively searching for volunteers. It was first posted in January 8th 2020 and has since been modified with its most recent update happening October 10th 2022. This research requires 32 participants from 4 distinct sites to be enrolled."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger